other material
confidence high
sentiment positive
materiality 0.60
PetVivo signs exclusive license for VetStem's PrecisePRP canine and equine products
PetVivo Holdings, Inc.
- Upfront license fee of $500,000; milestone payments up to $500,000 in $250,000 increments.
- PetVivo issues 1M shares valued at $1.0M and warrant for 250K shares at $1.25 exercise price.
- Royalties based on net sales; term expires later of 10 years after first commercial sale or last valid claim.
- Product is an off-the-shelf allogeneic freeze-dried PRP with consistent 4B platelets per vial; no blood draw required.